| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0b49572e98a174ecd1f02a935289973 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 |
| filingDate |
2004-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b92d110305a45b7f60684da872540e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c8a6046397c2e9a91b992b5179ccdcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a589e092016760fe0894f881041194d6 |
| publicationDate |
2005-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-200540188-A |
| titleOfInvention |
Peptide capable of combining with human tissue antigen and its amino acid sequence |
| abstract |
This invention is related to one kind of peptide with its amino acid sequence of antigen determination position being selected from S protein of SARS virus which is capable of combining with human tissue antigen to form a complex and induces a cytotoxic effect. The peptide can be collocated with appropriate carriers, adjuvant or thinners to manufacture vaccines or diagnosis reagents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021209035-A1 |
| priorityDate |
2004-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |